Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors-Reference-Cited by-同舟云学术

Gemcitabine-Based Chemotherapy in Adrenocortical Carcinoma: A Multicenter Study of Efficacy and Predictive Factors

Published:2017-09-19 Issue:11 Volume:102 Page:4323-4332
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Henning Judith E K,Deutschbein Timo,Altieri Barbara,Steinhauer Sonja,Kircher Stefan,Sbiera Silviu,Wild Vanessa,Schlötelburg Wiebke,Kroiss Matthias,Perotti Paola,Rosenwald Andreas,Berruti Alfredo,Fassnacht Martin,Ronchi Cristina L

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/102/11/4323/21533646/jc.2017-01624.pdf

Reference45 articles.

1. Adrenocortical carcinoma;Endocr Rev,2014

2. Update in adrenocortical carcinoma;J Clin Endocrinol Metab,2013

3. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a revised TNM classification;German Adrenocortical Carcinoma Registry Group;Cancer,2009

4. Prognostic factors in stage III-IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study;ENSAT Network;Ann Oncol,2015

5. EJE prize 2014: current and evolving treatment options in adrenocortical carcinoma: where do we stand and where do we want to go?;Eur J Endocrinol,2014

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical Treatment in Advanced Adrenocortical Carcinoma;Updates in Surgery;2024-07-25

2. Expertise Area 3.3: Adrenal cancer;Rare and Complex Urology;2024

3. PLK1 inhibitors as a new targeted treatment for adrenocortical carcinoma;Endocrine Connections;2023-11-22

4. Metabolic heterogeneity in adrenocortical carcinoma impacts patient outcomes;JCI Insight;2023-08-22

5. Outcome of adrenocortical carcinoma patients included in early phase clinical trials: Results from the French network ENDOCAN-COMETE;European Journal of Cancer;2023-08